Thymoquinone Crosstalks with DR5 to Sensitize TRAIL Resistance and Stimulate ROS-Mediated Cancer Apoptosis

OBJECTIVE: Cancer treatment using a targeted inducer of apoptosis like tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) faced the obstacle of resistance, thus providing a plus drug like Thymoquinone (TQ) could be of great interest to tackle breast cancer cells. The aim of the present...

Descripción completa

Detalles Bibliográficos
Autores principales: Abd-Rabou, Ahmed A, Abd El-Salam, Nagwa M, Sharada, Hayat M I, Abd EL Samea, Gehan G, Abdalla, Mohga S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850882/
https://www.ncbi.nlm.nih.gov/pubmed/34582654
http://dx.doi.org/10.31557/APJCP.2021.22.9.2855

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850882/
https://www.ncbi.nlm.nih.gov/pubmed/34582654
http://dx.doi.org/10.31557/APJCP.2021.22.9.2855

Ejemplares similares